Doxazosin mesylate

Product NDC: 59762-2320
11-digit product format: 597622320
Labeler code: 59762
Product ID: 59762-2320_7f8d22c7-a708-48c0-bc41-549a23e1f8c9
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: doxazosin mesylate
Dosage form: TABLET
Route: ORAL
Labeler: Greenstone LLC
Application: NDA019668
Marketing category: NDA AUTHORIZED GENERIC
Marketing start: 2014-07-07
Marketing end: 0000-00-00
Substance: DOXAZOSIN MESYLATE
Active strength: 2 mg/1
Pharmacologic classes: Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]
NDC exclude flag: No
Listing certified through: 2023-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	59762-2320		D	Discontinued by firm		2026-08-10
excluded package	package	59762-2320	59762-2320-6	D	Discontinued by firm		2026-08-10

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 24 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	59762-2320-6	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	59762-2320-6	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	59762-2320-6	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	59762-2320-6	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	59762-2320-6	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	59762-2320-6	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	59762-2320-6	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	59762-2320-6	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	59762-2320-6	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	59762-2320-6	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	59762-2320-6	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	59762-2320-6	`557ba5c1ecfa…`	`9c80585c8c6e…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 4 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N019668-001	CARDURA	DOXAZOSIN MESYLATE	EQ 1MG BASE	TABLET / ORAL	AB	RLD, RS	1990-11-02
N019668-002	CARDURA	DOXAZOSIN MESYLATE	EQ 2MG BASE	TABLET / ORAL	AB	RLD	1990-11-02
N019668-003	CARDURA	DOXAZOSIN MESYLATE	EQ 4MG BASE	TABLET / ORAL	AB	RLD	1990-11-02
N019668-004	CARDURA	DOXAZOSIN MESYLATE	EQ 8MG BASE	TABLET / ORAL	AB	RLD	1990-11-02

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 4 matching rows.

Application-product, TE code table
Application-product	TE code
N019668-001	AB
N019668-002	AB
N019668-003	AB
N019668-004	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 5 · 164 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N019668-001	CARDURA	EQ 1MG BASE	TABLET / ORAL	AB	RLD, RS	1990-11-02	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N019668-002	CARDURA	EQ 2MG BASE	TABLET / ORAL	AB	RLD	1990-11-02	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N019668-003	CARDURA	EQ 4MG BASE	TABLET / ORAL	AB	RLD	1990-11-02	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N019668-004	CARDURA	EQ 8MG BASE	TABLET / ORAL	AB	RLD	1990-11-02	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N019668-001	CARDURA	EQ 1MG BASE	TABLET / ORAL	AB	RLD, RS	1990-11-02	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N019668-002	CARDURA	EQ 2MG BASE	TABLET / ORAL	AB	RLD	1990-11-02	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N019668-003	CARDURA	EQ 4MG BASE	TABLET / ORAL	AB	RLD	1990-11-02	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N019668-004	CARDURA	EQ 8MG BASE	TABLET / ORAL	AB	RLD	1990-11-02	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N019668-001	CARDURA	EQ 1MG BASE	TABLET / ORAL	AB	RLD, RS	1990-11-02	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N019668-002	CARDURA	EQ 2MG BASE	TABLET / ORAL	AB	RLD	1990-11-02	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N019668-003	CARDURA	EQ 4MG BASE	TABLET / ORAL	AB	RLD	1990-11-02	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N019668-004	CARDURA	EQ 8MG BASE	TABLET / ORAL	AB	RLD	1990-11-02	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N019668-001	CARDURA	EQ 1MG BASE	TABLET / ORAL	AB	RLD, RS	1990-11-02	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N019668-002	CARDURA	EQ 2MG BASE	TABLET / ORAL	AB	RLD	1990-11-02	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N019668-003	CARDURA	EQ 4MG BASE	TABLET / ORAL	AB	RLD	1990-11-02	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N019668-004	CARDURA	EQ 8MG BASE	TABLET / ORAL	AB	RLD	1990-11-02	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N019668-001	CARDURA	EQ 1MG BASE	TABLET / ORAL	AB	RLD, RS	1990-11-02	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N019668-002	CARDURA	EQ 2MG BASE	TABLET / ORAL	AB	RLD	1990-11-02	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N019668-003	CARDURA	EQ 4MG BASE	TABLET / ORAL	AB	RLD	1990-11-02	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N019668-004	CARDURA	EQ 8MG BASE	TABLET / ORAL	AB	RLD	1990-11-02	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N019668-001	CARDURA	EQ 1MG BASE	TABLET / ORAL	AB	RLD, RS	1990-11-02	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N019668-002	CARDURA	EQ 2MG BASE	TABLET / ORAL	AB	RLD	1990-11-02	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N019668-003	CARDURA	EQ 4MG BASE	TABLET / ORAL	AB	RLD	1990-11-02	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N019668-004	CARDURA	EQ 8MG BASE	TABLET / ORAL	AB	RLD	1990-11-02	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N019668-001	CARDURA	EQ 1MG BASE	TABLET / ORAL	AB	RLD, RS	1990-11-02	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N019668-002	CARDURA	EQ 2MG BASE	TABLET / ORAL	AB	RLD	1990-11-02	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N019668-003	CARDURA	EQ 4MG BASE	TABLET / ORAL	AB	RLD	1990-11-02	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N019668-004	CARDURA	EQ 8MG BASE	TABLET / ORAL	AB	RLD	1990-11-02	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N019668-001	CARDURA	EQ 1MG BASE	TABLET / ORAL	AB	RLD, RS	1990-11-02	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N019668-002	CARDURA	EQ 2MG BASE	TABLET / ORAL	AB	RLD	1990-11-02	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N019668-003	CARDURA	EQ 4MG BASE	TABLET / ORAL	AB	RLD	1990-11-02	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N019668-004	CARDURA	EQ 8MG BASE	TABLET / ORAL	AB	RLD	1990-11-02	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N019668-001	CARDURA	EQ 1MG BASE	TABLET / ORAL	AB	RLD, RS	1990-11-02	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N019668-002	CARDURA	EQ 2MG BASE	TABLET / ORAL	AB	RLD	1990-11-02	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N019668-003	CARDURA	EQ 4MG BASE	TABLET / ORAL	AB	RLD	1990-11-02	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N019668-004	CARDURA	EQ 8MG BASE	TABLET / ORAL	AB	RLD	1990-11-02	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N019668-001	CARDURA	EQ 1MG BASE	TABLET / ORAL	AB	RLD, RS	1990-11-02	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N019668-002	CARDURA	EQ 2MG BASE	TABLET / ORAL	AB	RLD	1990-11-02	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N019668-003	CARDURA	EQ 4MG BASE	TABLET / ORAL	AB	RLD	1990-11-02	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N019668-004	CARDURA	EQ 8MG BASE	TABLET / ORAL	AB	RLD	1990-11-02	`d06236e962d9…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 5 · 164 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N019668-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N019668-002	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N019668-003	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N019668-004	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N019668-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N019668-002	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N019668-003	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N019668-004	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N019668-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N019668-002	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N019668-003	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N019668-004	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N019668-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N019668-002	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N019668-003	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N019668-004	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N019668-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N019668-002	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N019668-003	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N019668-004	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N019668-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N019668-002	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N019668-003	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N019668-004	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N019668-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N019668-002	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N019668-003	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N019668-004	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N019668-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N019668-002	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N019668-003	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N019668-004	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N019668-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N019668-002	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N019668-003	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N019668-004	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N019668-001	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N019668-002	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N019668-003	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N019668-004	AB	1	`d06236e962d9…`

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
07a517fc-5845-3816-0f81-0a121804ec9e	Product name	6	20250107
171dd63c-7eea-ede4-c010-4c25ba0a1087	Product name	1	20140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
59762-2320-6	Doxazosin mesylate	100 in 1 BOTTLE	TABLET	100		18

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
59762-2320-6	EA - Each	59762-2320	5b121ef9-8f5f-4c2d-a803-283c8aaddcd1	1	2014-08-01

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
DOXAZOSIN MESYLATE	ACTIVE INGREDIENT	86P6PQK0MU	DOXAZOSIN MESYLATE TABLET [GREENSTONE LLC]	2
DOXAZOSIN	ACTIVE MOIETY	NW1291F1W8	DOXAZOSIN MESYLATE TABLET [GREENSTONE LLC]	2
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	DOXAZOSIN MESYLATE TABLET [GREENSTONE LLC]	2
D&C YELLOW NO. 10	INACTIVE INGREDIENT	35SW5USQ3G	DOXAZOSIN MESYLATE TABLET [GREENSTONE LLC]	2
FD&C YELLOW NO. 6	INACTIVE INGREDIENT	H77VEI93A8	DOXAZOSIN MESYLATE TABLET [GREENSTONE LLC]	2
LACTOSE	INACTIVE INGREDIENT	J2B2A4N98G	DOXAZOSIN MESYLATE TABLET [GREENSTONE LLC]	2
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	DOXAZOSIN MESYLATE TABLET [GREENSTONE LLC]	2
SODIUM LAURYL SULFATE	INACTIVE INGREDIENT	368GB5141J	DOXAZOSIN MESYLATE TABLET [GREENSTONE LLC]	2
SODIUM STARCH GLYCOLATE TYPE A POTATO	INACTIVE INGREDIENT	5856J3G2A2	DOXAZOSIN MESYLATE TABLET [GREENSTONE LLC]	2

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
59762-2320	DOXAZOSIN MESYLATE TABLET DOXAZOSIN TABLET [MYLAN PHARMACEUTICALS INC.]	17	Legacy NDC, 1 package rows	20250511_6b887aa5-5edf-48c5-a480-dea8c35afa9d.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 7 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Doxazosin mesylate	DOXAZOSIN MESYLATE	Aphena Pharma Solutions - Tennessee, LLC	445dc831-1960-4b25-e063-6294a90a6efd	2025-11-24	Warnings, Adverse reactions	Exact identifier application applno (NDA): 019668 application number: NDA019668
Doxazosin	DOXAZOSIN	Aphena Pharma Solutions - Tennessee, LLC	3ab222b7-74cc-5343-e063-6294a90a9616	2025-07-24	Warnings, Adverse reactions	Exact identifier application applno (NDA): 019668 application number: NDA019668
Doxazosin mesylate	DOXAZOSIN MESYLATE	Mylan Pharmaceuticals Inc.	2e524986-7903-416f-b2b8-d27295103e75	2024-03-11	Warnings, Adverse reactions	Exact identifier application applno (NDA): 019668 application number: NDA019668
Cardura	DOXAZOSIN	Viatris Specialty LLC	5e1f5e49-2da1-43ab-9795-228a8bcc5a82	2023-10-15	Warnings, Adverse reactions	Exact identifier application applno (NDA): 019668 application number: NDA019668
Doxazosin	DOXAZOSIN	Aphena Pharma Solutions - Tennessee, LLC	b364c7a8-72b5-4776-a500-400c37a72c9b	2022-02-03	Warnings, Adverse reactions	Exact identifier application applno (NDA): 019668 application number: NDA019668
Doxazosin	DOXAZOSIN	Mylan Pharmaceuticals Inc.	6b887aa5-5edf-48c5-a480-dea8c35afa9d	2022-01-20	Warnings, Adverse reactions	Exact identifier application applno (NDA): 019668 application number: NDA019668 ndc (product): 59762-2320
Cardura	DOXAZOSIN	ROERIG	eefc47bc-c10f-49bb-8ef7-5999f798ab39	2022-01-20	Warnings, Adverse reactions	Exact identifier application applno (NDA): 019668 application number: NDA019668

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
86P6PQK0MU	DOXAZOSIN MESYLATE	77883-43-3	DOXAZOSIN MESYLATE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
197625	doxazosin mesylate 1 MG Oral Tablet	PSN	6b887aa5-5edf-48c5-a480-dea8c35afa9d	18
197626	doxazosin mesylate 2 MG Oral Tablet	PSN	6b887aa5-5edf-48c5-a480-dea8c35afa9d	18
197627	doxazosin mesylate 4 MG Oral Tablet	PSN	6b887aa5-5edf-48c5-a480-dea8c35afa9d	18
197628	doxazosin mesylate 8 MG Oral Tablet	PSN	6b887aa5-5edf-48c5-a480-dea8c35afa9d	18
197625	doxazosin 1 MG Oral Tablet	SCD	6b887aa5-5edf-48c5-a480-dea8c35afa9d	18
197626	doxazosin 2 MG Oral Tablet	SCD	6b887aa5-5edf-48c5-a480-dea8c35afa9d	18
197627	doxazosin 4 MG Oral Tablet	SCD	6b887aa5-5edf-48c5-a480-dea8c35afa9d	18
197628	doxazosin 8 MG Oral Tablet	SCD	6b887aa5-5edf-48c5-a480-dea8c35afa9d	18
197625	doxazosin (as doxazosin mesylate) 1 MG Oral Tablet	SY	6b887aa5-5edf-48c5-a480-dea8c35afa9d	18
197626	doxazosin (as doxazosin mesylate) 2 MG Oral Tablet	SY	6b887aa5-5edf-48c5-a480-dea8c35afa9d	18
197627	doxazosin (as doxazosin mesylate) 4 MG Oral Tablet	SY	6b887aa5-5edf-48c5-a480-dea8c35afa9d	18
197628	doxazosin (as doxazosin mesylate) 8 MG Oral Tablet	SY	6b887aa5-5edf-48c5-a480-dea8c35afa9d	18

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
59762-2320-6	59762232006	100 TABLET in 1 BOTTLE (59762-2320-6)	100 tablet	2014-07-07	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Doxazosin mesylate	Mylan Pharmaceuticals Inc.	2022-01-20	HUMAN PRESCRIPTION DRUG LABEL	19
Doxazosin mesylate	Aphena Pharma Solutions - Tennessee, LLC	2019-03-25	HUMAN PRESCRIPTION DRUG LABEL	1